Skeletal Dysplasia, Growth Hormone Treatment and Body Proportion: Comparison with Other Syndromic and Non-Syndromic Short Children

@article{Hagens2003SkeletalDG,
  title={Skeletal Dysplasia, Growth Hormone Treatment and Body Proportion: Comparison with Other Syndromic and Non-Syndromic Short Children},
  author={Lars Hagen{\"a}s and Thomas Hertel},
  journal={Hormone Research in Paediatrics},
  year={2003},
  volume={60},
  pages={65 - 70}
}
Skeletal dysplasias comprise a diverse group of conditions that usually compromise both linear growth and body proportions. It is of theoretical interest to evaluate the effect of GH treatment on linear growth, body proportion and final height in the different skeletal dysplasias. Reported experience of GH treatment in short children with skeletal dysplasia is sparse and often limited to short treatment periods and knowledge of its effects on final height and body proportion is generally… Expand
Acromesomelic Dysplasia, Type Maroteaux: Impact of Long-Term (8 Years) High-Dose Growth Hormone Treatment on Growth Velocity and Final Height in 2 Siblings
TLDR
The results confirm the finding of relative GH resistance in AMDM, which when overcome with high-dose GH treatment resulted in improved height SDS during childhood and adolescence and associated quality of life. Expand
Growth Hormone Axis in Skeletal Dysplasias
TLDR
Evaluate retrospectively the data on growth, final height (FH), height velocity (HV), growth hormone deficiency, and growth hormone response after growth hormone (GH) treatment in patients with these disorders. Expand
Chapter 1 Growth Hormone Axis in Skeletal Dysplasias
Introduction: Skeletal dysplasias, also termed as osteochondrodysplasias, are a large heterogeneous group of disorders characterized by abnormalities of bone or cartilage growth or texture. TheyExpand
Efficacy and Safety of Growth Hormone Treatment in Children with Hypochondroplasia: Comparison with an Historical Cohort
Background/Aims: Hypochondroplasia (HCH) is a skeletal dysplasia characterized by disproportionate short stature. The aims of the study are to evaluate efficacy and safety of recombinant human growthExpand
Growth hormone analysis and treatment in Ellis–van Creveld syndrome
TLDR
The present results indicate that GH treatment may improve growth in at least some patients with EvC, and it is concluded that EvC patients may benefit from being tested for GHD and, if indicated, treated. Expand
Growth and Growth Hormone Therapy in Subjects With Mulibrey Nanism
TLDR
The patients with mulibrey nanism showed a distinct postnatal growth pattern and the growth hormone treatment was safe and induced a good short-term effect, but the impact on the adult height remained modest. Expand
Growth hormone effect on body composition in Turner syndrome
TLDR
There were differences between patients with TS patients and normal healthy women, and there was an association between all groups with regards to BMI, waist, SHR, and leg/H, but not in percentage of fat mass. Expand
Achondroplasia: from genotype to phenotype.
TLDR
The diagnosis of achondroplasia is based on typical clinical and radiological features including short stature, macrocephaly with frontal bossing, midface hypoplasia and rhizomelic shortening of the limbs. Expand
Body proportions in children with Kabuki syndrome
TLDR
Based on deviations in body proportions it was shown possible to discern children with KS from normally proportioned controls, and knowledge of body proportions in KS may contribute to better insight into the growth pattern and characterization of this genetic disorder. Expand
Metabolic Bone Disease in Children
TLDR
This article analyzes primary and secondary osteoporosis, rickets, osteomalacia, and some genetic bone diseases and discusses the role of exercise and pharmacologic therapy with calcium, vitamin D, phosphate, bisphosphonates, calcitonin, sex hormones, growth hormone, and thiazides. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 26 REFERENCES
A multicentre trial of recombinant growth hormone and low dose oestrogen in Turner syndrome: near final height analysis
TLDR
Final height gain was modest at 4.6 cm and low dosage ethinyloestradiol before planned induction of puberty was not beneficial, and younger, shorter girls gained greatest height advantage from GH. Expand
Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height.
A cardinal clinical feature of Turner syndrome (TS) is linear growth failure resulting in extreme short stature: the median adult height of untreated women with TS is 143 cm, 20 cm (8 in.) below thatExpand
Response to growth hormone in children with chondrodysplasia.
TLDR
The data suggest that the abnormal growth cartilage in patients with chondrodysplasia responds to GH therapy, and the effect on final height cannot be predicted with the currently available data. Expand
Effect of growth hormone therapy in children with achondroplasia: growth pattern, hypothalamic-pituitary function, and genotype.
TLDR
It is concluded that GH might be beneficial in the treatment of short stature in children with achondroplasia in the first 2 years of treatment. Expand
Growth in diastrophic dysplasia.
TLDR
DTD interferes profoundly with normal growth and results in progressive growth failure of varying severity; the growth charts should prove useful in following up an individual patient with DTD and may be used to predict adult height and to evaluate growth-promoting therapies. Expand
Human growth hormone treatment in prepubertal children with achondroplasia.
TLDR
It is shown that r-hGH can safely increase short-term growth velocity in some but not all prepubertal children with achondroplasia, and the individual variability in the response to the GH treatment is confirmed. Expand
Treatment of Achondroplasia with Growth Hormone: Six Years of Experience
We describe the effects of recombinant hGH (r-hGH) therapy for up to 6 y on stature and body proportions of 35 children with achondroplasia (Ach). Consecutive height (Ht) measurements were plotted onExpand
Growth in Cartilage-Hair Hypoplasia
TLDR
The growth of 100 Finnish patients and present cartilage-hair hypoplasia-specific growth charts of height and weight for height are useful for assessment of growth, prediction of adult height, detection of superimposed disorders, and evaluation of growth-accelerating therapy. Expand
Growth Hormone (GH) Treatment in Achondroplasia
TLDR
It is concluded that parameters reflecting hypothalamic-pituitary function, particularly GH secretion, should be examined in achondroplasia patients, and that GH treatment may be beneficial in the treatment of short stature in a chondroPLasia. Expand
Achondroplasia: Effect of Growth Hormone in 40 Patients
TLDR
Although the annual height gain in the second year of GH treatment was less than in the first year, it was still greater than before GH treatment, and the lower limb length to height ratio was significantly increased by GH treatment. Expand
...
1
2
3
...